Tocilizumab Prophylaxis Following Idecabtagene Vicleucel in the Outpatient Setting in Patients with Relapsed or Refractory Multiple Myeloma

Transplantation and Cellular Therapy 2026

View at publisher

Authors: Edward M. Peres, Shatha Farhan, Josephine Emole, Muneer Hyder Abidi, Asif Alavi, Cameron Peres

DOI: 10.1016/j.jtct.2025.12.278

Cited by: 0

Fields of Study & Subjects

CAR-T cell therapy research Multiple Myeloma Research and Treatments Immunotherapy and Immune Responses